NCT06762821 A 24-month Outcomes of Single- Vs Multiple-visit Revascularization
| NCT ID | NCT06762821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Minia University |
| Condition | Necrotic Immature Permanent Incisors |
| Study Type | INTERVENTIONAL |
| Enrollment | 86 participants |
| Start Date | 2024-12-21 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 86 participants in total. It began in 2024-12-21 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current randomized clinical trial will be conducted to evaluate the 24-month clinical and radiographic outcomes after revascularization of asymptomatic necrotic immature permanent maxillary incisors using single- or multiple-visit protocol.
Eligibility Criteria
Inclusion Criteria: * Compliant healthy patients who had at least one immature maxillary permanent incisor requiring nonsurgical root canal treatment. * Patients presenting with a diagnosis of pulp necrosis with chronic apical periodontitis confirmed by history, clinical, radiographic and operative examination. * Patient without previous endodontic treatment in affected tooth. Exclusion Criteria: * Patients with systemic conditions (medical, developmental or behavioral) that make routine dental treatment difficult. * Patients taking medications that can interfere with healing or hemostasis. * Patients with allergy to local anesthetics * Children who will not comply to recall program. * Teeth with extensive loss of coronal tissue that require restoration with a post * Teeth with internal or external root resorption
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06762821 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 13 Years, studying Necrotic Immature Permanent Incisors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06762821 currently recruiting?
Yes, NCT06762821 is actively recruiting participants. Contact the research team at osama.seif@mu.edu.eg for enrollment information.
Where is the NCT06762821 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT06762821 clinical trial?
NCT06762821 is sponsored by Minia University. The trial plans to enroll 86 participants.